Delivery Order SPE2DB22D2007-SPE2DB24FJ3PX

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used for the treatment of HIV infection. The contract has a ceiling value of $151,316.79 and a period of performance through July 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,157.17 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $11,981.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used for the treatment of HIV-1 infection. The contract has an ultimate completion date of December 26, 2023 and is a firm fixed-price agreement. It is not designated as a set-aside contract, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,501.84 Firm Fixed Price Delivery Order is for the supply of 4567140553 - BIKTARVY 50-200-25 MG TABLET UU 30S, a medication used in the treatment of HIV/AIDS. The contract has an ultimate completion date of February 4, 2025 and is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,035.68 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used to treat HIV infection. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $104,744.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract provides for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. This is a pharmaceutical product used in the treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,512.54 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used in the treatment of HIV. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,094.52 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $58,302.06 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition. The contract provides for the delivery of BIKTARVY 50-200-25 MG TABLET medication, which is used to treat HIV. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,326.01 delivery order contract, awarded by the Defense Logistics Agency (DLA), is for the supply of the HIV medication BIKTARVY 50-200-25 MG TABLET. The contract has a firm fixed price and runs through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3PX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,470.72 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used in the treatment of HIV/AIDS. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:57 AM